Companies: 10,795·Total market cap: $144.5T
Innate Pharma S.A.

Innate Pharma S.A.

IPHANASDAQHealthcare● Active
$1.76
+$0.05(+2.92%)
Market Cap$165269787
P/E Ratio—
52W High$2.63
52W Low$1.17
Cash on HandFinancialsRevenue

Innate Pharma S.A. (IPHA) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

IPHA · cash on hand · updated Dec 31, 2025

Core cash position

Cash & Short-Term Investments (CCE + ST Investments)
$34.3M▼ -57.5% vs prior year
FY · as of Dec 31, 2025 · Reported in EUR
Cash & Cash Equiv. (CCE)
$28.1M
cashAndCashEquivalents
Short-Term Investments
$6.2M
shortTermInvestments
YoY Change vs Prior Year
-57.5%
vs prior fiscal year
Latest Quarter
$34.3M
Q4 2025
Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in EUR

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: December 31, 2025

Net cash vs debt

Cash & ST Investments$34.3MCash on Hand
Total Debt$22.6MTotal Debt
Net Cash / Net Debt+$11.7MNet Cash Position
Cash vs Debt Ratio
Cash 60%Debt 40%

Innate Pharma S.A. has a net cash position of $11.7M, holding more cash than debt.

Net Cash = Cash & ST Investments − Total Debt$34.3M − $22.6M = +$11.7M

Cash on hand history

YoY Increase
YoY Decrease
Latest Year
IPHA annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

DateCash & ST InvestmentsYoY Change
Dec 31, 2025Latest$34.3M-57.5%
Dec 31, 2024$80.8M-12.6%
Dec 31, 2023$92.5M-8.9%
Dec 31, 2022$101.5M-15.3%
Dec 31, 2021$119.8M-21.0%
IPHA cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

#CompanyCash & ST Inv.Cash/MCap
#1
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$28.12B7.6%#2
Johnson & Johnson
Johnson & Johnson
JNJ
$20.10B3.6%#3
Eli Lilly and Company
Eli Lilly and Company
LLY
$7.27B0.7%#4
AbbVie Inc.
AbbVie Inc.
ABBV
$5.26B1.3%
#5
Innate Pharma S.A.
Innate Pharma S.A.YOU
IPHA
$34.3M20.8%
Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

Innate Pharma S.A. (IPHA) cash on hand as of December 31, 2025 is $34.3M, comprising $28.1M in cash and cash equivalents (CCE) plus $6.2M in short-term investments — reported as Innate Pharma S.A. cash and short-term investments on the balance sheet (10-K filing). Also referred to as Innate Pharma S.A. cash reserves or cash position.

Innate Pharma S.A. annual cash on hand history shows decreased -57.5% in 2025: decreased -57.5% in 2025. Innate Pharma S.A. cash reserves in 2025 reflect the company's capital allocation strategy.

Innate Pharma S.A. carries total debt of $22.6M against cash of $34.3M, resulting in a net cash position of +$11.7M. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.
Financial statementsFree cash flowNet incomeRevenueMarket capP/E ratioEarningsPrice history

Frequently asked questions

IPHA cash on hand · 5 questions

As of December 31, 2025, Innate Pharma S.A. (IPHA) has $34,295,397 in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $28,080,043 in cash and cash equivalents (CCE) plus $6,215,354 in short-term investments. Latest quarter (December 31, 2025): $34,295,397. Data sourced from the annual 10-K filing via FMP.

IPHA cash on handIPHA cash reservesIPHA cash 2025how much cash does IPHA have

▸ Source: FMP /balance-sheet-statement · US GAAP · Innate Pharma S.A. · Innate Pharma S.A. SEC 10-K & 10-Q filings · US GAAP · Last updated: December 31, 2025